How botulinum and tetanus neurotoxins block neurotransmitter release

Biochimie

Volumn 82, Issue 5, 2000, Pages 427-446

  Humeau, Yann ^a   Doussau, Frédéric ^a   Grant, Nancy J ^b   Poulain, Bernard ^a  

^a CTRS   (France)

^b CENTRE DE NEUROCHIMIE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLCHOLINE; BOTULINUM TOXIN; METALLOPROTEINASE; PROTEIN GLUTAMINE GAMMA GLUTAMYLTRANSFERASE; PROTEIN KINASE C; SNARE PROTEIN; SYNAPTOBREVIN; SYNAPTOSOMAL ASSOCIATED PROTEIN 25; SYNTAXIN; TETANUS TOXIN;

BOTULISM; CLOSTRIDIUM BOTULINUM; CLOSTRIDIUM TETANI; CYTOSKELETON; ENZYME ACTIVITY; EXOCYTOSIS; INHIBITION KINETICS; MEMBRANE FUSION; NEUROMUSCULAR BLOCKING; NEUROTRANSMISSION; NEUROTRANSMITTER RELEASE; NEUROTRANSMITTER UPTAKE; NONHUMAN; PROTEIN DEGRADATION; PROTEIN INTERACTION; REVIEW; SYNAPSE VESICLE; TETANUS; TOXIN ANALYSIS;

BACTERIA (MICROORGANISMS); CLOSTRIDIUM BOTULINUM; CLOSTRIDIUM TETANI;

EID: 0034121745     PISSN: 03009084     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0300-9084(00)00216-9     Document Type: Article

References (221)

1. Carle A., Rattone G. Studio esperimentale sull'eziologia del tetano. Giorn. Accad. Mede. Torino. 32:1884;174-179.
2. Van Ermengen E. Über einem neuen anaeroben Bacillus und seine Beziehungen zum Botulisms. Z. Hyg. Infeckt. Krankh. 26:1897;1-56.
3. Pitzura M. The history of tetanus. Nistico G, Bizzini B, Bytchneko B, Triau R. Eight International Conference on Tetanus. 1989;1-15 Pyrthagora Press, Rome-Milan.
4. Simpson L.L. Botulinum neurotoxin and tetanus toxin. 1989;Academic Press Inc, San Diego.
5. Niemann H. Molecular Biology of Clostridial neurotoxins. Alouf J.E, Freer J.H. Sourcebook of bacterial protein toxins. 1991;303-348 Academic Press, San Diego.
6. Montecucco C. Clostridial neurotoxins. Curr. Topics Microbiol. Immunol. 195:1995;1-278.
7. Burgen A.S.V., Dickens F., Zatman L.J. The action of botulinum toxin on neuromuscular junction. J. Physiol. (Lond.). 109:1949;10-24.
8. Simpson L.L. The origin, structure, and pharmacological activity of botulinum toxin. Pharmacol. Rev. 33:1981;155-188.
9. Eisel U., Jarausch W., Goretzki K., Henschen A., Engels J., Weller U., Hudel M., Habermann E., Niemann H. Tetanus toxin: primary structure, expression in E. coli, and homology with botulinum toxins. EMBO J. 5:1986;2495-2502.
10. Binz T., Kurazono H., Wille M., Frevert J., Wernars K., Niemann H. The complete sequence of botulinum neurotoxin type A and comparison with other clostridial neurotoxins. J. Biol. Chem. 265:1990;9153-9158.
11. Schiavo G., Benfenati F., Poulain B., Rossetto O., Polverino De Laureto P., DasGupta B.R., Montecucco C. Tetanus and botulinum-B neurotoxins block neurotransmitter release by proteolytic cleavage of synaptobrevin. Nature. 359:1992;832-835.
12. Schiavo G., Poulain B., Rossetto O., Benfenati F., Tauc L., Montecucco C. Tetanus toxin is a zinc protein and its inhibition of neurotransmitter release and protease activity depend on zinc. EMBO J. 11:1992;3577-3583.
13. Niemann H., Blasi J., Jahn R. Clostridial neurotoxins: new tools for dissecting exocytosis. Trends Cell Biol. 4:1994;179-185.
14. Montecucco C., Schiavo G. Structure and function of tetanus and botulinum neurotoxins. Q. Rev. Biophys. 28:1995;423-472.
15. Lacy D.B., Tepp W., Cohen A.C., DasGupta B.R., Stevens R.C. Crystal structure of botulinum neurotoxin type A and implications for toxicity. Nat. Struct. Biol. 5:1998;898-902.
16. Schantz E.J., Johnson E.A. Properties and use of botulinum toxin and other microbial neurotoxins in medicine. Microbiol. Rev. 56:1992;80-99.
17. Popoff M.R. Ecology of neurotoxigenic strains of clostridia. Curr. Top. Microbiol. Immunol. 195:1995;1-29.
18. Herreros J., Lalli G., Montecucco C., Schiavo G. Pathophysiological properties of clostridial neurotoxins. Freer J.H, Alouf J.E. The Comprehensive Sourcebook of Bacterial Protein Toxins. 1999;202-228 Academic Press, London.
19. Aktories K. Rho proteins: targets for bacterial toxins. Trends Microbiol. 5:1997;282-288.
20. Popoff M.R. Interactions between bacterial toxins and intestinal cells. Toxicon. 36:1998;665-685.
21. DasGupta B.R. The Structure of Botulinum Neurotoxin. Simpson L.L. Botulinum neurotoxin and tetanus toxin. 1989;53-67 Academic Press Inc, San Diego.
22. Ahnert-Hilger G., Weller U., Dauzenroth M.E., Habermann E., Gratzl M. The tetanus toxin light chain inhibits exocytosis. FEBS Lett. 242:1989;245-248.
23. Stecher B., Gratzl M., Ahnert-Hilger G. Reductive chain separation of botulinum A toxin - a prerequisite to its inhibitory action on exocytosis in chromaffin cells. FEBS Lett. 248:1989;23-27.
24. Popoff M.R., Marvaud J.C. Structural and genomic features of clostridial neurotoxins. Freer J.H, Alouf J.E. The Comprehensive Sourcebook of Bacterial Protein Toxins. 1999;202-228 Academic Press, London.
25. Molgó J., Comella J.X., Angaut-Petit D., Pecot-Dechavassine M., Tabti N., Faille L., Mallart A., Thesleff S. Presynaptic actions of botulinal neurotoxins at vertebrate neuromuscular junctions. J. Physiol. (Paris). 84:1990;152-166.
26. Chen F., Kuziemko G.M., Stevens R.C. Biophysical characterization of the stability of the 150-kilodalton botulinum toxin, the nontoxic component, and the 900-kilodalton botulinum toxin complex species. Infect. Immun. 1998;2420-2425.
27. Simpson L.L. Molecular pharmacology of botulinum toxin and tetanus toxin. Annu. Rev. Pharmacol. Toxicol. 26:1986;427-453.
28. Tackets N., Rogawski N. Botulism. Simpson L.L. Botulinum neurotoxin and tetanus toxin. 1989;351-378 Academic Press Inc, San Diego.
29. Hatheway C.L. Botulism: the present status of the disease. Curr. Top. Microbiol. Immunol. 195:1995;55-75.
30. Tyler H.R. Botulinus toxin: effect on the central nervous system of man. Science. 139:1963;847-848.
31. Wiegand H., Wellhoner H.H. The action of botulinum A neurotoxin on the inhibition by antidromic stimulation of the lumbar monosynaptic reflex. Naunyn Schmiedebergs Arch. Pharmacol. 298:1977;235-238.
32. Moreno-Lopez B., De La Cruz R.R., Pastor A.M., Delgado-Garcia J.M. Botulinum neurotoxin alters the discharge characteristics of abducens motoneurons in the alert cat. J. Neurophysiol. 72:1994;2041-2044.
33. Santini M., Fabri S., Sagnelli P., Manfredi M., Francia A. Botulism: a case associated with pyramidal signs. Eur. J. Neurol. 6:1999;91-93.
34. Curtis D.R., De Groat W.C. Tetanus toxin and spinal inhibition. Brain Res. 10:1968;208-212.
35. Habermann E., Dreyer F., Bigalke H. Tetanus toxin blocks the neuromuscular transmission in vitro like botulinum A toxin. Naunyn Schmiedebergs Arch. Pharmacol. 311:1980;33-40.
36. Bevan S., Wendon L.M. A study of the action of tetanus toxin at rat soleus neuromuscular junctions. J. Physiol. (Lond.). 348:1984;1-17.
37. Boroff D.A., Del Castillo J., Evoy W.H., Steinhardt R.A. Observations on the action of type A botulinum toxin on frog neuromuscular junctions. J. Physiol. (Lond.). 240:1974;227-253.
38. Kao I., Drachman D.B., Price D.L. Botulinum toxin: mechanism of presynaptic blockade. Science. 193:1976;1256-1258.
39. Cull-Candy S.G., Lundh H., Thesleff S. Effects of botulinum toxin on neuromuscular transmission in the rat. J. Physiol. (Lond.). 260:1976;177-203.
40. Dreyer F., Schmitt A. Transmitter release in tetanus and botulinum A toxin-poisoned mammalian motor endplates and its dependence on nerve stimulation and temperature. Pflugers. Arch. 399:1983;228-234.
41. Bambrick L., Gordon T. Acetylcholine receptors and sodium channels in denervated and botulinum-toxin-treated adult rat muscle. J. Physiol. (Lond.). 382:1987;69-86.
42. Koltgen D., Ceballos-Baumann A.O., Franke C. Botulinum toxin converts muscle acetylcholine receptors from adult to embryonic type. Muscle Nerve. 17:1994;779-784.
43. Molgó J., Van der Kloot W., Poulain B. Neurotoxins affecting the quantal acetylcholine release from vertebrate motor nerve terminals. Int. Rev. Cytol. 00:2000.
44. Van der Kloot W, Molgó J. Quantal acetylcholine release at the vertebrate neuromuscular junction. Physiol. Rev. 74:1994;915-926.
45. Meir A., Ginsburg S., Butkevich A., Kachalsky S.G., Kaiserman I., Ahdut R., Demirgoren S., Rahamimoff R. Ion channels in presynaptic nerve terminals and control of transmitter release. Physiol. Rev. 79:1999;1019-1088.
46. Gundersen C.B., Katz B., Miledi R. The reduction of endplate responses by botulinum toxin. Proc. R. Soc. Lond. B. Biol. Sci. 213:1981;489-493.
47. Menestrina G., Schiavo G., Montecucco C. Molecular mechanisms of action of bacterial protein toxins. Mol. Aspects M. 15:1994;79-193.
48. Halpern J.L., Neale E.A. Neurospecific binding, internalization, and retrograde axonal transport. Curr. Top. Microbiol. Immunol. 195:1995;221-241.
49. Mochida S., Poulain B., Weller U., Habermann E., Tauc L. Light chain of tetanus toxin intracellularly inhibits acetylcholine release at neuro-neuronal synapses, and its internalization is mediated by heavy chain. FEBS Lett. 253:1989;47-51.
50. Bittner M.A., DasGupta B.R., Holz R.W. Isolated light chains of botulinum neurotoxins inhibit exocytosis. Studies in digitonin-permeabilized chromaffin cells. J. Biol. Chem. 264:1989;10354-10360.
51. De Paiva A., Dolly J.O. Light chain of botulinum neurotoxin is active in mammalian motor nerve terminals when delivered via liposomes. FEBS Lett. 277:1990;171-174.
52. Poulain B., Tauc L., Maisey E.A., Wadsworth J.D., Mohan P.M., Dolly J.O. Neurotransmitter release is blocked intracellularly by botulinum neurotoxin, and this requires uptake of both toxin polypeptides by a process mediated by the larger chain. Proc. Natl. Acad. Sci. USA. 85:1988;4090-4094.
53. Kurazono H., Mochida S., Binz T., Eisel U., Quanz M., Grebenstein O., Wernars K., Poulain B., Tauc L., Niemann H. Minimal essential domains specifying toxicity of the light chains of tetanus toxin and botulinum neurotoxin type A. J. Biol. Chem. 267:1992;14721-14729.
54. Jongeneel C.V., Bouvier J., Bairoch A. A unique signature identifies a family of zinc-dependent metallopeptidases. FEBS Lett. 242:1989;211-214.
55. Wright J.F., Pernollet M., Reboul A., Aude C., Colomb M.G. Identification and partial characterization of a low affinity metal-binding site in the light chain of tetanus toxin. J. Biol. Chem. 267:1992;9053-9058.
56. Schiavo G., Rossetto O., Santucci A., DasGupta B.R., Montecucco C. Botulinum neurotoxins are zinc proteins. J. Biol. Chem. 267:1992;23479-23483.
57. Schiavo G., Shone C.C., Bennett M.K., Scheller R.H., Montecucco C. Botulinum neurotoxin type C cleaves a single Lys-Ala bond within the carboxyl-terminal region of syntaxins. J. Biol. Chem. 270:1995;10566-10570.
58. Simpson L.L., Coffield J.A., Bakry N. Chelation of zinc antagonizes the neuromuscular blocking properties of the seven serotypes of botulinum neurotoxin as well as tetanus toxin. J. Pharmacol. Exp. Ther. 267:1993;720-727.
59. De Paiva A., Ashton A.C., Foran P., Schiavo G., Montecucco C., Dolly J.O. Botulinum A like type B and tetanus toxins fulfils criteria for being a zinc-dependent protease. J. Neurochem. 61:1993;2338-2341.
60. Dayanithi G., Stecher B., Hohne-Zell B., Yamasaki S., Binz T., Weller U., Niemann H., Gratzl M. Exploring the functional domain and the target of the tetanus toxin light chain in neurohypophysial terminals. Neuroscience. 58:1994;423-431.
61. Sheridan R.E., Deshpande S.S. Interactions between heavy metal chelators and botulinum neurotoxins at the mouse neuromuscular junction. Toxicon. 33:1995;539-549.
62. Fu F.N., Lomneth R.B., Cai S., Singh B.R. Role of zinc in the structure and toxic activity of botulinum neurotoxin. Biochemistry. 37:1998;5267-5278.
63. 3H]-noradrenaline release by the light chain of tetanus toxin. Naunyn Schmiedeberg's Arch. Pharmacol. 346:1992;358-361.
64. Deshpande S.S., Sheridan R.E., Adler M. A study of zinc-dependent metalloendopeptidase inhibitors as pharmacological antagonists in botulinum neurotoxin poisoning. Toxicon. 33:1995;551-557.
65. Adler M., Nicholson J.D., Cornille F., Hackley B.E. Jr. Efficacy of a novel metalloprotease inhibitor on botulinum neurotoxin B activity. FEBS Lett. 429:1998;234-238.
66. Martin L., Cornille F., Turcaud S., Meudal H., Roques B.P., Fournie-Zaluski M.C. Metallopeptidase inhibitors of tetanus toxin: A combinatorial approach. J. Med. Chem. 42:1999;515-525.
67. Meneghini C., Morante S. The active site structure of tetanus neurotoxin resolved by multiple scattering analysis in X-ray absorption spectroscopy. Biophys. J. 75:1998;1953-1963.
68. Niemann H., Binz T., Grebenstein O., Kurazono H., Kalkuhl A., Yamasaki S., Eisel U., Pohlner J., Schneider G., Krivan V., Kozaki S., Mochida S., Tauc L., Poulain B. DasGupta B.R. Botulinum and Tetanus Neurotoxins: Neurotransmission and Biochemical Aspects. 1993;361-375 Plenum, New York.
69. Yamasaki S., Hu Y., Binz T., Kalkuhl A., Kurazono H., Tamura T., Jahn R., Kandel E., Niemann H. Synaptobrevin/vesicle-associated membrane protein (VAMP) of Aplysia californica: structure and proteolysis by tetanus toxin and botulinal neurotoxins type D and F. Proc. Natl. Acad. Sci. USA. 91:1994;4688-4692.
70. Li Y., Foran P., Fairweather N.F., de Paiva A., Weller U., Dougan G., Dolly J.O. A single mutation in the recombinant light chain of tetanus toxin abolishes its proteolytic activity and removes the toxicity seen after reconstitution with native heavy chain. Biochemistry. 33:1994;7014-7020.
71. Niemann H., Blasi J., Jahn R. Clostridial neurotoxins: new tools for dissecting exocytosis. Trends Cell Biol. 4:1994;179-185.
72. Washbourne P., Pellizzari R., Baldini G., Wilson M.C., Montecucco C. Botulinum neurotoxin types A and E require the SNARE motif in SNAP-25 for proteolysis. FEBS Lett. 418:1997;1-5.
73. Vaidyanathan V.V., Yoshino K., Jahnz M., Dorries C., Bade S., Nauenburg S., Niemann H., Binz T. Proteolysis of SNAP-25 isoforms by botulinum neurotoxin types A, C, and E: domains and amino acid residues controlling the formation of enzyme-substrate complexes and cleavage. J. Neurochem. 72:1999;327-337.
74. Hansen N.J., Antonin W., Edwardson J.M. Identification of SNAREs involved in regulated exocytosis in the pancreatic acinar cell. J. Biol. Chem. 274:1999;22871-22876.
75. Coffield J.A., Bakry N., Zhang R.D., Carlson J., Gomella L.G., Simpson L.L. In vitro characterization of botulinum toxin types A, C and D action on human tissues: combined electrophysiologic, pharmacologic and molecular biologic approaches. J. Pharmacol. Exp. Ther. 280:1997;1489-1498.
76. Rossetto O., Schiavo G., Montecucco C., Poulain B., Deloye F., Lozzi L., Shone C.C. SNARE motif and neurotoxins. Nature. 372:1994;415-416.
77. Pellizzari R., Rossetto O., Lozzi L., Giovedi S., Johnson E., Shone C.C., Montecucco C. Structural determinants of the specificity for synaptic vesicle-associated membrane protein/synaptobrevin of tetanus and botulinum type B and G neurotoxins. J. Biol. Chem. 271:1996;20353-20358.
78. Pellizzari R., Mason S., Shone C.C., Montecucco C. The interaction of synaptic vesicle-associated membrane protein/synaptobrevin with botulinum neurotoxins D and F. FEBS Lett. 409:1997;339-342.
79. Cornille F., Martin L., Lenoir C., Cussac D., Roques B.P., Fournie-Zaluski M.C. Cooperative exosite-dependent cleavage of synaptobrevin by tetanus toxin light chain. J. Biol. Chem. 272:1997;3459-3464.
80. Hua S.Y., Charlton M.P. Activity-dependent changes in partial VAMP complexes during neurotransmitter release. Nat. Neurosci. 2:1999;1078-1083.
81. Hayashi T., Mc Mahon H., Yamasaki S., Binz T., Hata Y., Südhof T.C., Niemann H. Synaptic vesicle membrane fusion complex: action of clostridial neurotoxins on assembly. EMBO J. 13:1994;5051-5061.
82. Pellegrini L.L., O' Connor V., Betz H. Fusion complex formation protects synaptobrevin against proteolysis by tetanus toxin light chain. FEBS Lett. 353:1994;319-323.
83. Sutton R.B., Fasshauer D., Jahn R., Brunger A.T. Crystal structure of a SNARE complex involved in synaptic exocytosis at 2.4 A resolution. Nature. 395:1998;347-353.
84. Hohne-Zell B., Gratzl M. Adrenal chromaffin cells contain functionally different SNAP-25 monomers and SNAP-25/syntaxin heterodimers. FEBS Lett. 394:1996;109-116.
85. Margittai M., Otto H., Jahn R. A stable interaction between syntaxin 1a and synaptobrevin 2 mediated by their transmembrane domains. FEBS Lett. 446:1999;40-44.
86. Schiavo G., Stenbeck G., Rothman J.E., Söllner T.H. Binding of the synaptic vesicle v-SNARE, synaptotagmin, to the plasma membrane t-SNARE, SNAP-25, can explain docked vesicles at neurotoxin-treated synapses. Proc. Natl. Acad. Sci. USA. 94:1997;997-1001.
87. Calakos N., Scheller R.H. Vesicle-associated membrane protein and synaptophysin are associated on the synaptic vesicle. J. Biol. Chem. 269:1994;24534-24537.
88. Xu T., Rammner B., Margittai M., Artalejo A.R., Neher E., Jahn R. Inhibition of SNARE complex assembly differentially affects kinetic components of exocytosis. Cell. 99:1999;713-722.
89. Hunt J.M., Bommert K., Charlton M.P., Kistner A., Habermann E., Augustine G.J., Betz H. A post-docking role for synaptobrevin in synaptic vesicle fusion. Neuron. 12:1994;1269-1279.
90. Poulain B., Rossetto O., Deloye F., Schiavo G., Tauc L., Montecucco C. Antibodies against rat brain vesicle-associated membrane protein (synaptobrevin) prevent inhibition of acetylcholine release by tetanus toxin or botulinum neurotoxin type B. J. Neurochem. 61:1993;1175-1178.
91. Raciborska D.A., Trimble W.S., Charlton M.P. Presynaptic protein interactions in vivo: evidence from botulinum A, C, D and E action at frog neuromuscular junction. Eur. J. Neurosci. 10:1998;2617-2628.
92. Hua S.Y., Raciborska D.A., Trimble W.S., Charlton M.P. Different VAMP/synaptobrevin complexes for spontaneous and evoked transmitter release at the crayfish neuromuscular junction. J. Neurophysiol. 80:1998;3233-3246.
93. 2+-induced insulin exocytosis. EMBO J. 15:1996;6951-6959.
94. Bruns D., Engers S., Yang C., Ossig R., Jeromin A., Jahn R. Inhibition of transmitter release correlates with the proteolytic activity of tetanus toxin and botulinus toxin A in individual cultured synapses of Hirudo medicinalis. J. Neurosci. 17:1997;1898-1910.
95. Sadoul K., Berger A., Niemann H., Regazzi R., Catsicas S., Halban P.A. SNAP-25 can self-associate to form a disulfide-linked complex. J. Biol. Chem. 378:1997;1171-1176.
96. Dunant Y., Esquerda J.E., Loctin F., Marsal J., Muller D. Botulinum toxin inhibits quantal acetylcholine release and energy metabolism in the Torpedo electric organ. J. Physiol. (Lond.). 385:1987;677-692.
97. Rabasseda X., Blasi J., Marsal J., Dunant Y., Casanova A., Bizzini B. Tetanus and botulinum toxins block the release of acetylcholine from slices of rat striatum and from the isolated electric organ of Torpedo at different concentrations. Toxicon. 26:1988;329-336.
98. Dreyer F., Rosenberg F., Becker C., Bigalke H., Penner R. Differential effects of various secretagogues on quantal transmitter release from mouse motor nerve terminals treated with botulinum A and tetanus toxin. Naunyn Schmiedebergs Arch. Pharmacol. 335:1987;1-7.
99. Gansel M., Penner R., Dreyer F. Distinct sites of action of clostridial neurotoxins revealed by double-poisoning of mouse motor nerve terminals. Pflugers Arch. 409:1987;533-539.
100. Kauffman J.A., Way J.F. Jr., Siegel L.S., Sellin L.C. Comparison of the action of types A and F botulinum toxin at the rat neuromuscular junction. Toxicol. Appl. Pharmacol. 79:1985;211-217.
101. Molgó J., Siegel L.S., Tabti N., Thesleff S. A study of synchronization of quantal transmitter release from mammalian motor endings by the use of botulinal toxins type A and D. J. Physiol. (Lond.). 411:1989;195-205.
102. Trimble W.S., Gray T.S., Elferink L.A., Wilson M.C., Scheller R.H. Distinct patterns of expression of two VAMP genes within the rat brain. J. Neurosci. 10:1990;1380-1387.
103. Li J.Y., Edelmann L., Jahn R., Dahlstrom A. Axonal transport and distribution of synaptobrevin I and II in the rat peripheral nervous system. J. Neurosci. 16:1996;137-147.
104. 2+ partially rescues synaptic transmission in hippocampal cultures treated with botulinum toxin A and C, but not tetanus toxin. J. Neurosci. 17:1997;7190-7202.
105. Sweeney S.T., Broadie K., Keane J., Niemann H., O' Kane C.J. Targeted expression of tetanus toxin light chain in Drosophila specifically eliminates synaptic transmission and causes behavioral defects. Neuron. 14:1995;341-351.
106. Broadie K., Prokop A., Bellen H.J., O' Kane C.J., Schulze K.L., Sweeney S.T. Syntaxin and synaptobrevin function downstream of vesicle docking in Drosophila. Neuron. 15:1995;663-673.
107. Deitcher D.L., Ueda A., Stewart B.A., Burgess R.W., Kidokoro Y., Schwarz T.L. Distinct requirements for evoked and spontaneous release of neurotransmitter are revealed by mutations in the Drosophila gene neuronal-synaptobrevin. J. Neurosci. 18:1998;2028-2039.
108. 2+ increases and by cAMP. J. Neurosci. 19:1999;2432-2441.
109. Foran P., Lawrence G.W., Shone C.C., Foster K.A., Dolly J.O. Botulinum neurotoxin C1 cleaves both syntaxin and SNAP-25 in intact and permeabilized chromaffin cells: correlation with its blockade of catecholamine release. Biochemistry. 35:1996;2630-2636.
110. Williamson L.C., Halpern J.L., Montecucco C., Brown J.E., Neale E.A. Clostridial neurotoxins and substrate proteolysis in intact neurons: botulinum neurotoxin C acts on synaptosomal-associated protein of 25 kDa. J. Biol. Chem. 271:1996;7694-7699.
111. Blasi J., Chapman E.R., Yamasaki S., Binz T., Niemann H., Jahn R. Botulinum neurotoxin C1 blocks neurotransmitter release by means of cleaving HPC-1/syntaxin. EMBO J. 12:1993;4821-4828.
112. O' Connor V., Heuss C., De Bello W.M., Dresbach T., Charlton M.P., Hunt J.H., Pellegrini L.L., Hodel A., Burger M.M., Betz H., Augustine G.J., Schafer T. Disruption of syntaxin-mediated protein interactions blocks neurotransmitter secretion. Proc. Natl. Acad. Sci. USA. 94:1997;12186-12191.
113. Marsal J., Ruiz-Montasell B., Blasi J., Moreira J.E., Contreras D., Sugimori M., Llinas R. Block of transmitter release by botulinum C1 action on syntaxin at the squid giant synapse. Proc. Natl. Acad. Sci. USA. 94:1997;14871-14876.
114. Hayashi T., Yamasaki S., Nauenburg S., Binz T., Niemann H. Disassembly of the reconstituded synaptic vesicle membrane fusion complex in vitro. EMBO J. 14:1995;2317-2325.
115. Chapman E.R., An S., Barton N., Jahn R. SNAP-25, a t-SNARE which binds to both syntaxin and synaptobrevin via domains that may form coiled coils. J. Biol. Chem. 269:1994;27427-27432.
116. Pellegrini L.L., O'Connor V., Lottspeich F., Betz H. Clostridial neurotoxins compromise the stability of a low energy SNARE complex mediating NSF activation of synaptic vesicle fusion. EMBO J. 14:1995;4705-4713.
117. Hao J.C., Salem N., Peng X.R., Kelly R.B., Bennett M.K. Effect of mutations in vesicle-associated membrane protein (VAMP) on the assembly of multimeric protein complexes. J. Neurosci. 17:1997;1596-1603.
118. 2+ and drives membrane fusion. Cell. 97:1999;165-174.
119. Lawrence G.W., Foran P., Mohammed N., DasGupta B.R., Dolly J.O. Importance of two adjacent C-terminal sequences of SNAP-25 in exocytosis from intact and permeabilized chromaffin cells revealed by inhibition with botulinum neurotoxins A and E. Biochemistry. 36:1997;3061-3067.
120. Xu T., Binz T., Niemann H., Neher E. Multiple kinetic components of exocytosis distinguished by neurotoxin sensitivity. Nat. Neurosci. 1:1998;192-200.
121. Tahara M., Coorssen J.R., Timmers K., Blank P.S., Whalley T., Scheller R., Zimmerberg J. Calcium can disrupt the SNARE protein complex on sea urchin egg secretory vesicles without irreversibly blocking fusion. J. Biol. Chem. 273:1998;33667-33673.
122. Ilardi J.M., Mochida S., Sheng Z.H. Snapin: a SNARE-associated protein implicated in synaptic transmission. Nat. Neurosci. 2:1999;119-124.
123. Poirier M.A., Hao J.C., Malkus P.N., Chan C., Moore M.F., King D.S., Bennett M.K. Protease resistance of syntaxin. SNAP-25. VAMP complexes. Implications for assembly and structure. J. Biol. Chem. 273:1998;11370-11377.
124. Fassio A., Sala R., Bonanno G., Marchi M., Raiteri M. Evidence for calcium-dependent vesicular transmitter release insensitive to tetanus toxin and botulinum toxin type F. Neuroscience. 90:1999;893-902.
125. Verderio C., Coco S., Bacci A., Rossetto O., De Camilli P., Montecucco C., Matteoli M. Tetanus toxin blocks the exocytosis of synaptic vesicles clustered at synapses but not of synaptic vesicles in isolated axons. J. Neurosci. 19:1999;6723-6732.
126. Salem N., Faundez V., Horng J.T., Kelly R.B. A v-SNARE participates in synaptic vesicle formation mediated by the AP3 adaptor complex. Nat. Neurosci. 1:1998;551-556.
127. Cornille F., Deloye F., Fournié-Zaluski M.C., Roques B.P., Poulain B. Inhibition of neurotransmitter release by synthetic prolin-rich peptides shows that the N-terminal domain of vesicle associated membrane protein/synaptobrevin is critical for neuro-exocytosis. J. Biol. Chem. 270:1995;16826-16832.
128. Gutierrez L.M., Viniegra S., Rueda J., Ferrer-Montiel A.V., Canaves J.M., Montal M. A peptide that mimics the C-terminal sequence of SNAP-25 inhibits secretory vesicle docking in chromaffin cells. J. Biol. Chem. 272:1997;2634-2639.
129. Ferrer-Montiel A.V., Gutierrez L.M., Apland J.P., Canaves J.M., Gil A., Viniegra S., Biser J.A., Adler M., Montal M. The 26-mer peptide released from SNAP-25 cleavage by botulinum neurotoxin E inhibits vesicle docking. FEBS Lett. 435:1998;84-88.
130. Sellin L.C., Kauffman J.A., DasGupta B.R. Comparison of the effects of botulinum neurotoxin types A and E at the rat neuromuscular junction. Med. Biol. 61:1983;120-125.
131. De Paiva A., Meunier F.A., Molgó J., Aoki K.R., Dolly J.O. Functional repair of motor endplates after botulinum neurotoxin type A poisoning: biphasic switch of synaptic activity between nerve sprouts and their parent terminals. Proc. Natl. Acad. Sci. USA. 96:1999;3200-3205.
132. Sellin L.C., Thesleff S., DasGupta B.R. Different effects of types A and B botulinum toxin on transmitter release at the rat neuromuscular junction. Acta Physiol. Scand. 119:1983;127-133.
133. Eleopra R., Tugnoli V., Rossetto O., De Grandis D., Montecucco C. Different time courses of recovery after poisoning with botulinum neurotoxin serotypes A and E in humans. Neurosci. Lett. 256:1998;135-138.
134. Keller J.E., Neale E.A., Oyler G., Adler M. Persistence of botulinum neurotoxin action in cultured spinal cord cells. FEBS Lett. 456:1999;137-142.
135. Raciborska D.A., Charlton M.P. Retention of cleaved synaptosome-associated protein of 25 kDa (SNAP-25) in neuromuscular junctions: a new hypothesis to explain persistence of botulinum A poisoning. Can. J. Physiol. Pharmacol. 77:1999;679-688.
136. O'Sullivan G.A., Mohammed N., Foran P.G., Lawrence G.W., Dolly J.O. Rescue of exocytosis in botulinum toxin A-poisoned chromaffin cells by expression of cleavage-resistant SNAP-25. Identification of the minimal essential C-terminal residues. J. Biol. Chem. 274:1999;36897-36904.
137. 2+)-dependent protease activity is removed. J. Biol. Chem. 270:1995;31386-31390.
138. Facchiano F., Luini A. Tetanus toxin potently stimulates tissue transglutaminase. A possible mechanism of neurotoxicity. J. Biol. Chem. 267:1992;13267-13271.
139. Facchiano F., Benfenati F., Valtorta F., Luini A. Covalent modification of synapsin I by a tetanus toxin-activated transglutaminase. J. Biol. Chem. 268:1993;4588-4591.
140. Deloye F., Poulain B., Luini A., Facchiano F. Intraneuronal transglutaminases are required for blockade of neurotransmitter release by tetanus toxin. Toxicon. 34:1996;1086-1087.
141. Marxen P., Bigalke H. Tetanus and botulinum A toxins inhibit stimulated F-actin rearrangement in chromaffin cells. NeuroReport. 2:1991;33-36.
142. Eisel U., Reynolds K., Riddick M., Zimmer A., Niemann H., Zimmer A. Tetanus toxin light chain expression in Sertoli cells of transgenic mice causes alterations of the actin cytoskeleton and disrupts spermatogenesis. EMBO J. 12:1993;3365-3372.
143. Presek P., Jessen S., Dreyer F., Jarvie P.E., Findik D., Dunkley P.R. Tetanus toxin inhibits depolarization-stimulated protein phosphorylation in rat cortical synaptosomes: effect on synapsin I phosphorylation and translocation. J. Neurochem. 59:1992;1336-1343.
144. DasGupta B.R., Tepp W. Protease activity of botulinum neurotoxin type E and its light chain: cleavage of actin. Biochem. Biophys. Res. Commun. 190:1993;470-474.
145. Aguilera J., Yavin E. In vivo translocation and down-regulation of protein kinase C following intraventricular administration of tetanus toxin. J. Neurochem. 54:1990;339-342.
146. Aguilera J., Padros-Giralt C., Habig W.H., Yavin E. GT1b ganglioside prevents tetanus toxin-induced protein kinase C activation and down-regulation in the neonatal brain in vivo. J. Neurochem. 60:1993;709-713.
147. Gil C., Ruiz-Meana M., Alava M., Yavin E., Aguilera J. Tetanus toxin enhances protein kinase C activity translocation and increases polyphosphoinositide hydrolysis in rat cerebral cortex preparations. J. Neurochem. 70:1998;1636-1643.
148. Ho J.L., Klempner M.S. Diminished activity of protein kinase C in tetanus toxin-treated macrophages and in the spinal cord of mice manifesting generalized tetanus intoxication. J. Infect. Dis. 157:1988;925-933.
149. Sandberg K., Berry C.J., Eugster E., Rogers T.B. A role for cGMP during tetanus toxin blockade of acetylcholine release in the rat pheochromocytoma (PC12) cell line. J. Neurosci. 9:1989;3946-3954.
150. 3H]5-hydroxytryptamine uptake in rat synaptosomes. Biochem. Pharmacol. 57:1999;111-120.
151. Najib A., Pelliccioni P., Gil C., Aguilera J. Clostridium neurotoxins influence serotonin uptake and release differently in rat brain synaptosomes. J. Neurochem. 72:1999;1991-1998.
152. Scott A.B. Botulinum toxin injection into extraocular muscles as an alternative to strabismus surgery. Ophthalmology. 87:1980;1044-1049.
153. Jankovic J., Hallett M. Therapy with Botulinum Toxin. 1994;Marcel Dekker, Inc, New-York, Basel, Hong Kong.
154. Gangarosa E.J., Donadio J.A., Armstrong R.W., Meyer K.F., Brachman P.S., Dowell V.R. Botulism in the United States, 1899-1969. Am. J. Epidemiol. 93:1971;93-101.
155. Galazka A., Gasse F. The present status of tetanus and tetanus vaccination. Curr. Topic Microbiol. Immunol. 195:1995;31-53.
156. Simpson L.L., DasGupta B.R. Botulinum neurotoxin type E: studies on mechanism of action and on structure-activity relationships. J. Pharmacol. Exp. Ther. 224:1983;135-140.
157. Molgó J., DasGupta B.R., Thesleff S. Characterization of the actions of botulinum neurotoxin type E at the rat neuromuscular junction. Acta. Physiol. Scand. 137:1989;497-501.
158. Kim Y.I., Lomo T., Lupa M.T., Thesleff S. Miniature end-plate potentials in rat skeletal muscle poisoned with botulinum toxin. J. Physiol. (Lond.). 356:1984;587-599.
159. Adler M., Macdonald D.A., Sellin L.C., Parker G.W. Effect of 3,4-diaminopyridine on rat extensor digitorum longus muscle paralyzed by local injection of botulinum neurotoxin. Toxicon. 34:1996;237-249.
160. Wieszt L., Dreyer F. Mode of action of botulinum toxin E on the transmitter release process at the mouse neuromuscular junction. Naunyn Schmiedeberg Arch. Pharmacol. 344:1991;R74.
161. Lomneth R., Suszkiw J.B., DasGupta B.R. Response of the chick ciliary ganglion-iris neuromuscular preparation to botulinum neurotoxin. Neurosci. Lett. 113:1990;211-216.
162. Miyazaki S., Sakaguchi G. Experimental botulism in chickens: the cecum as the site of production and absorption of botulinum toxin. Jpn. J. Med. Sci. Biol. 31:1978;1-15.
163. Molgó J., Thesleff S. Studies on the mode of action of botulinum toxin type A at the frog neuromuscular junction. Brain Res. 297:1984;309-316.
164. Coffield J.A., Bakry N.M., Maksymowych A.B., Simpson L.L. Characterization of a vertebrate neuromuscular junction that demonstrates selective resistance to botulinum toxin. J. Pharmacol. Exp. Ther. 289:1999;1509-1516.
165. Harris A.J., Miledi R. The effect of type D botulinum toxin on frog neuromuscular junctions. J. Physiol. (Lond.). 217:1971;497-515.
166. Mellanby J., Thompson P.A. The effect of tetanus toxin at the neuromuscular junction in the goldfish. J. Physiol. (Lond.). 224:1972;407-419.
167. Herreros J., Miralles F.X., Solsona C., Bizzini B., Blasi J., Marsal J. Tetanus toxin inhibits spontaneous quantal release and cleaves VAMP/synaptobrevin. Brain Res. 699:1995;165-170.
168. Poulain B., Weller U., Binz T., Niemann H., De Paiva A., Dolly O., Leprince C., Tauc L. DasGupta B.R. Botulinum and tetanus neurotoxins. 1993;345-360 Plenum Press, New-York.
169. Poulain B., Wadsworth J.D., Shone C.C., Mochida S., Lande S., Melling J., Dolly O., Tauc L. Multiple domains of botulinum neurotoxin contribute to its inhibition of transmitter release in Aplysia neurons. J. Biol. Chem. 264:1989;21928-21933.
170. Llinas R., Sugimori M., Chu D., Morita M., Blasi J., Herreros J., Jahn R., Marsal J. Transmission at the squid giant synapse was blocked by tetanus toxin by affecting synaptobrevin, a vesicle-bound protein. J. Physiol. (Lond.). 477:1994;129-133.
171. Schulze K.L., Broadie K., Perin M.S., Bellen H.J. Genetic and electrophysiological studies of Drosophila syntaxin-1A demonstrate its role in non-neuronal secretion and neurotransmission. Cell. 80:1995;311-320.
172. Lupa M.T., Tabti N. Facilitation, augmentation and potentiation of transmitter release at frog neuromuscular junctions poisoned with botulinum toxin. Pflugers Arch. 406:1986;636-640.
173. 2+ exchange. Brain Res. 410:1987;385-389.
174. Mallart A., Molgó J., Angaut-Petit D., Thesleff S. Is the internal calcium regulation altered in type A botulinum toxin-poisoned motor endings? Brain Res. 479:1989;167-171.
175. 2+-free medium is associated with depletion of synaptic vesicles and swelling of motor nerve terminals in situ. Neuroscience. 78:1997;883-893.
176. Dreyer F., Schmitt A. Different effects of botulinum A toxin and tetanus toxin on the transmitter releasing process at the mammalian neuromuscular junction. Neurosci. Lett. 26:1981;307-311.
177. Duchen L.W., Tonge D.A. The effects of tetanus toxin on neuromuscular transmission and on the morphology of motor end-plates in slow and fast skeletal muscle of the mouse. J. Physiol. (Lond.). 228:1973;157-172.
178. Lundh H., Leander S., Thesleff S. Antagonism of the paralysis produced by botulinum toxin in the rat. The effects of tetraethylammonium, guanidine and 4-aminopyridine. J. Neurol. Sci. 32:1977;29-43.
179. Simpson L.L. A preclinical evaluation of aminopyridines as putative therapeutic agents in the treatment of botulism. Infect. Immun. 52:1986;858-862.
180. Molgó J., Lemeignan M., Thesleff S. Aminoglycosides and 3,4-diaminopyridine on neuromuscular block caused by botulinum type A toxin. Muscle Nerve. 10:1987;464-470.
181. Nishimura M., Kozaki S., Sakaguchi G. Zinc antagonizes the effect of botulinum type A toxin at the mouse neuromuscular junction. Experientia. 44:1988;18-20.
182. Mellanby J., Beaumont M.A., Thompson P.A. The effect of lanthanum on nerve terminals in goldfish muscle after paralysis with tetanus toxin. Neuroscience. 25:1988;1095-1106.
183. Pumplin D.W., Reese T.S. Action of brown widow spider venom and botulinum toxin on the frog neuromuscular junction examined with the freeze-fracture technique. J. Physiol. (Lond.). 273:1977;443-457.
184. Capogna M., Gahwiler B.H., Thompson S.M. Presynaptic inhibition of calcium-dependent and -independent release elicited with ionomycin, gadolinium, and alpha-latrotoxin in the hippocampus. J. Neurophysiol. 75:1996;2017-2028.
185. Pecot-Dechavassine M., Molgó J., Thesleff S. Ultrastructure of botulinum type-A poisoned frog motor nerve terminals after enhanced quantal transmitter release caused by carbonyl cyanide m-chlorophenylhydrazone. Neurosci. Lett. 130:1991;5-8.
186. Niles W.D., Malik A.B. Endocytosis and exocytosis events regulate vesicle traffic in endothelial cells. J. Membr. Biol. 167:1999;85-101.
187. Neale E.A., Habig W.H., Schrier B.K., Bergey G.K., Bowers L.M., Koh J. Applications of tetanus toxin for structure-function studies in neuronal cell cultures. Nistico G, Bizzini B, Bytchenko B, Triau R. Eight International Conference on Tetanus. 1989;58-65 Pythogora Press, Rome, Milan.
188. Gundersen C.B., Katz B., Miledi R. The antagonism between botulinum toxin and calcium in motor nerve terminals. Proc. R. Soc. Lond. B. Biol. Sci. 216:1982;369-376.
189. Dreyer F., Mallart A., Brigant J.L. Botulinum A toxin and tetanus toxin do not affect presynaptic membrane currents in mammalian motor nerve endings. Brain Res. 270:1983;373-375.
190. 2+ channel activity. Neuroscience. 65:1995;905-915.
191. Fisher R.J., Burgoyne R.D. The effect of transfection with Botulinum neurotoxin C1 light chain on exocytosis measured in cell populations and by single-cell amperometry in PC12 cells. Pflugers Arch. 437:1999;754-762.
192. Penner R., Neher E., Dreyer F. Intracellularly injected tetanus toxin inhibits exocytosis in bovine adrenal chromaffin cells. Nature. 324:1986;76-78.
193. Marxen P., Fuhrmann U., Bigalke H. Gangliosides mediate inhibitory effects of tetanus and botulinum A neurotoxins on exocytosis in chromaffin cells. Toxicon. 27:1989;849-859.
194. 2+-dependent noradrenaline release from permeabilised PC12 cells is blocked by botulinum neurotoxin A or its light chain. FEBS Lett. 261:1990;323-326.
195. Ahnert-Hilger G., Weller U. Comparison of the intracellular effects of clostridial neurotoxins on exocytosis from streptolysin O-permeabilized rat pheochromocytoma (PC 12) and bovine adrenal chromaffin cells. Neuroscience. 53:1993;547-552.
196. 2+-dependent exocytosis. J. Biol. Chem. 271:1996;20227-20230.
197. Hohne-Zell B., Galler A., Schepp W., Gratzl M., Prinz C. Functional importance of synaptobrevin and SNAP-25 during exocytosis of histamine by rat gastric enterochromaffin-like cells. Endocrinology. 138:1997;5518-5526.
198. 2+-but not for GTP gamma S-induced insulin secretion. EMBO J. 14:1995;2723-2730.
199. Gaisano H.Y., Sheu L., Foskett J.K., Trimble W.S. Tetanus toxin light chain cleaves a vesicle-associated membrane protein (VAMP) isoform 2 in rat pancreatic zymogen granules and inhibits enzyme secretion. J. Biol. Chem. 269:1994;17062-17066.
200. Fujita-Yoshigaki J., Dohke Y., Hara-Yokoyama M., Kamata Y., Kozaki S., Furuyama S., Sugiya H. Vesicle-associated membrane protein 2 is essential for cAMP-regulated exocytosis in rat parotid acinar cells. The inhibition of cAMP-dependent amylase release by botulinum neurotoxin B. J. Biol. Chem. 271:1996;13130-13134.
201. Flaumenhaft R., Croce K., Chen E., Furie B., Furie B.C. Proteins of the exocytotic core complex mediate platelet alpha-granule secretion. Roles of vesicle-associated membrane protein, SNAP-23, and syntaxin 4. J. Biol. Chem. 274:1999;2492-2501.
202. Steinhardt R.A., Bi G., Alderton J.M. Cell membrane resealing by a vesicular mechanism similar to neurotransmitter release. Science. 263:1994;390-393.
203. Avery J., Hodel A., Whitaker M. In vitro exocytosis in sea urchin eggs requires a synaptobrevin-related protein. J. Cell. Sci. 110:1997;1555-1561.
204. Ikebuchi Y., Masumoto N., Matsuoka T., Yokoi T., Tahara M., Tasaka K., Miyake A., Murata Y. SNAP-25 is essential for cortical granule exocytosis in mouse eggs. Am. J. Physiol. 274:1998;1496-1500.
205. Hackam D.J., Rotstein O.D., Sjolin C., Schreiber A.D., Trimble W.S., Grinstein S. v-SNARE-dependent secretion is required for phagocytosis. Proc. Natl. Acad. Sci. USA. 95:1998;11691-11696.
206. + secretion is inhibited by clostridial toxins in an inner medullary collecting duct cell line. Am. J. Physiol. 273:1997;1054-1057.
207. Banerjee A., Shih T., Alexander E.A., Schwartz J.H. SNARE proteins regulate H(+)-ATPase redistribution to the apical membrane in rat renal inner medullary collecting duct cells. J. Biol. Chem. 274:1999;26518-26522.
208. Galli T., Chilcote T., Mundigl O., Binz T., Niemann H., De Camilli P. Tetanus toxin-mediated cleavage of cellubrevin impairs exocytosis of transferrin receptor-containing vesicles in CHO cells. J. Cell. Biol. 125:1994;1015-1024.
209. Lledo P.M., Zhang X., Südhof T.C., Malenka R.C., Nicoll R.A. Postsynaptic membrane fusion and long-term potentiation. Science. 279:1998;399-403.
210. Chen F., Foran P., Shone C.C., Foster K.A., Melling J., Dolly J.O. Botulinum neurotoxin B inhibits insulin-stimulated glucose uptake into 3T3-Li adipocytes and cleaves cellubrevin unlike type A toxin which failed to proteolyse the SNAP-23 present. Biochemistry. 36:1997;5719-5728.
211. Shone C.C., Roberts A.K. Peptide substrate specificity and properties of the zinc-endopeptidase activity of botulinum type B neurotoxin. Eur. J. Biochem. 225:1994;263-270.
212. Foran P., Shone C.C., Dolly J.O. Differences in the protease activities of tetanus and botulinum B toxins revealed by the cleavage of vesicle-associated membrane protein and various sized fragments. Biochemistry. 33:1994;15365-15374.
213. Schiavo G., Shone C.C., Rossetto O., Alexander F.C., Montecucco C. Botulinum neurotoxin serotype F is a zinc endopeptidase specific for VAMP/synaptobrevin. J. Biol. Chem. 268:1993;11516-11519.
214. Yamasaki S., Baumeister A., Binz T., Blasi J., Link E., Cornille F., Roques B., Fykse E.M., Südhof T., Jahn R., Niemann H. Cleavage of members of the synaptobrevin/VAMP family by types D and F botulinal neurotoxins and tetanus toxin. J. Biol. Chem. 269:1994;12764-12772.
215. Schiavo G., Rossetto O., Catsicas S., Polverino De Laureto P., DasGupta B.R., Benfenati F., Montecucco C. Identification of the nerve terminal targets of botulinum neurotoxin serotypes A, D, and E. J. Biol. Chem. 268:1993;23784-23787.
216. Yamasaki S., Binz T., Hayashi T., Szabo E., Yamasaki N., Eklund M., Jahn R., Niemann H. Botulinum neurotoxin type G proteolyzes the Ala81-Ala82 bond of Rat synaptobrevin 2. Biochem. Biophys. Res. Commun. 200:1994;829-835.
217. Mc Mahon H.T., Ushkaryov Y.A., Edelmann L., Link E., Binz T., Niemann H., Jahn R., Südhof T.C. Cellubrevin is a ubiquitous tetanus-toxin substrate homologous to a putative synaptic vesicle fusion protein. Nature. 364:1993;346-349.
218. Galli T., Zahraoui A., Vaidyanathan V.V., Raposo G., Tian J.M., Karin M., Niemann H., Louvard D. A novel tetanus neurotoxin-insensitive vesicle-associated membrane protein in SNARE complexes of the apical plasma membrane of epithelial cells. Mol. Biol. Cell. 9:1998;1437-1448.
219. Chin A.C., Burgess R.W., Wong B.R., Schwarz T.L., Scheller R.H. Differential expression of transcripts from syb, a Drosophila melanogaster gene encoding VAMP (synaptobrevin) that is abundant in non-neuronal cells. Gene. 131:1993;175-181.
220. Binz T., Blasi J., Yamasaki S., Baumeister A., Link E., Südhof T.C., Jahn R., Niemann H. Proteolysis of SNAP-25 by types E and A botulinal neurotoxins. J. Biol. Chem. 269:1994;1617-1620.
221. Blasi J., Chapman E.R., Link E., Binz T., Yamasaki S., De Camilli P., Südhof T.C., Niemann H., Jahn R. Botulinum neurotoxin A selectively cleaves the synaptic protein SNAP-25. Nature. 365:1993;160-163.